What are the risks from aerosol-generating procedures in the treatment of patients with COVID-19?

Published: Nov. 26, 2021, 11:48 a.m.

b'Do hospitalised COVID-19 patients receiving treatment with CPAP and HFNOT present a significant added risk of viral contamination to the surrounding environment used by healthcare workers?\\nAnd is there enough evidence to suggest or recommend levels of PPE that should be used for healthcare workers caring for patients on CPAP or HFNOT?\\nTwo of the main questions this short podcast addresses. Rachael Moses, Multimedia Editor Thorax BMJ, interviews Dr Chris Green, Consultant in Infectious Diseases & General (Internal) Medicine, University Hospitals Birmingham NHS Foundation Trust.\\nRead the two related papers:\\nSARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures - https://thorax.bmj.com/content/early/2021/11/01/thoraxjnl-2021-218035\\nCoughs and sneezes spread diseases: but do \\u2018aerosol generating\\u2019 procedures? - https://thorax.bmj.com/content/early/2021/11/10/thoraxjnl-2021-218133'